IP Library Granted Patent US 7,943,670
Granted Patent B2
US 7,943,670 · App. 10/571,437 · Granted May 17, 2011

Liquid formulations of ractopamine

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,943,670
App. No.
10/571,437
Granted
May 17, 2011
Kind
B2
Abstract

Described is a soluble stable liquid formulation, process for preparing, and a method of using the soluble stable liquid formulation comprising ractopamine or a physiologically acceptable salt thereof, a liquid nonionic cosolvent, and water.

Claims (10)

1. A solubilized stabilized liquid formulation comprising from 10 to 30% w/w of ractopamine or a physiologically acceptable salt thereof; from 20 to 90% w/w of a liquid nonionic cosolvent selected from polyethoxylated sorbitan fatty acid esters, polyethoxylated vegetables oils, or both; and 5 to 75% w/w water.

2. The solubilized stabilized liquid formulation of claim 1 comprising 10 to 20% w/w ractopamine or a physiologically acceptable salt thereof, 30 to 80% w/w of a liquid nonionic cosolvent selected from polyethoxylated sorbitan fatty acid esters, polyethoxylated vegetable oils or both, and 10 to 60% w/w water.

3. The solubilized stabilized liquid formulation of claim 1 comprising 10 to 15% ractopamine or a physiologically acceptable salt thereof; from 40 to 55% liquid nonionic cosolvent selected from polyethoxylated sorbitan fatty acid esters, polyethoxylated vegetable oils, or both; and 35 to 50% water.

4. The solubilized stabilized liquid formulation of claim 3 wherein the nonionic cosolvent is a polyethoxylated sorbitan fatty acid ester.

5. The solubilized stabilized liquid formulation of claim 3 wherein the nonionic cosolvent is a polyethoxylated vegetable oil.

6. The solubilized stabilized liquid formulation of claim 4 wherein the nonionic cosolvent is polyoxythylene 20 sorbitan monolaurate.

7. The solubilized stabilized liquid formulation of claim 6 wherein ractopamine or a physiologically acceptable salt thereof is ractopamine hydrochloride.

8. A process for preparing a solubilized stabilized liquid formulation comprising:

admixing ractopamine or a physiologically acceptable salt thereof with water and a liquid nonionic cosolvent selected from polyethoxylated sorbitan fatty acid esters, polyethoxylated vegetable oils, or both; and heating the mixture to no higher than 100° C. to afford a stabilized and solubilized formulation comprising from 10 to 30% w/w ractopamine or a physiologically acceptable salt thereof; from 20 to 90% w/w of a liquid nonionic cosolvent selected from polyethoxylated sorbitan fatty acid esters, polyethoxylated vegetable oils, or both; and, from 5 to 75% w/w water.

9. A method of increasing weight gain, improving the efficiency of feed utilization, increasing leanness, decreasing lipogenesis, increasing lipolysis, increasing muscle protein synthesis, decreasing muscle protein breakdown, or an improvement in carcass quality of a ruminant, a swine or a turkey comprising administering to the ruminant, swine or turkey an effective amount of a solubilized stabilized liquid formulation of claim 1 .

Assignments (4)
ASSIGNMENT OF SECURITY INTEREST IN PATENT RIGHTS, RECORDED ON AUGUST 3, 2020, AT REEL/FRAME 053388/0967 Recorded Dec 3, 2025
From: GOLDMAN SACHS BANK USA, AS RETIRING COLLATERAL AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 073816/0021 →
SECURITY INTEREST Recorded Aug 3, 2020
From: ELANCO US INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 053388/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: ELI LILLY AND COMPANY
To: ELANCO US INC.
Reel/Frame 044696/0088 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2006
From: BURTON, MICHAEL DAVID SR.; KLINK, PAUL REUBEN
To: ELI LILLY AND COMPANY
Reel/Frame 018775/0660 →